Cuartero MI, García-Culebras A, Nieto-Vaquero C et al. Br J Pharmacol. 2024 Mar;181(6):816-839. doi: 10.1111/bph.16167. Epub 2023 Jul 12.. PMID: 37328270
https://pubmed.ncbi.nlm.nih.gov/37328270/
Abstract: In recent years, increasing evidence suggests that commensal microbiota may play animportant role not only in health but also in disease including cerebrovascular dis-ease. Gut microbes impact physiology, at least in part, by metabolizing dietary factorsand host-derived substrates and then generating active compounds including toxins.The purpose of this current review is to highlight the complex interplay betweenmicrobiota, their metabolites. and essential functions for human health, ranging fromregulation of the metabolism and the immune system to modulation of brain devel-opment and function. We discuss the role of gut dysbiosis in cerebrovascular disease,specifically in acute and chronic stroke phases, and the possible implication of intesti-nal microbiota in post-stroke cognitive impairment and dementia, and we identifypotential therapeutic opportunities of targeting microbiota in this context.
Funding: This work was supported by grants from the Spanish Ministry ofScience and Innovation (Ministerio de Ciencia e Innovacion [MCIN])(PID2019-106581RB-I00 [MAM] and PID2020-117765RB-I00 [JP]),from Leducq Foundation for Cardiovascular Research (TNE19CVD01[MAM and MIC] and TNE-21CVD04 [MAM and IL]) and from Insti-tuto de Salud Carlos III (ISCIII) and co-financed by the EuropeanDevelopment Regional Fund‘A Way to Achieve Europe’(PI20/00535) and RICORS-ICTUS (RD21/0006/0001 [IL]). CNIC issupported by ISCIII, MCIN and ProCNIC Foundation and is a SeveroOchoa Center of Excellence (CEX2020-001041-S)